Glycan profiling shows unvaried N-glycomes in MSC clones with distinct differentiation potentials by Ungar, Daniel et al.
ORIGINAL RESEARCH
published: 31 May 2016
doi: 10.3389/fcell.2016.00052
Frontiers in Cell and Developmental Biology | www.frontiersin.org 1 May 2016 | Volume 4 | Article 52
Edited by:
Simone Pacini,
University of Pisa, Italy
Reviewed by:
Simone Diestel,
University of Bonn, Germany
Amar M. Singh,
Transposagen Biopharmaceuticals,
USA
*Correspondence:
Daniel Ungar
dani.ungar@york.ac.uk
Specialty section:
This article was submitted to
Stem Cell Research,
a section of the journal
Frontiers in Cell and Developmental
Biology
Received: 21 March 2016
Accepted: 13 May 2016
Published: 31 May 2016
Citation:
Wilson KM, Thomas-Oates JE,
Genever PG and Ungar D (2016)
Glycan Profiling Shows Unvaried
N-Glycomes in MSC Clones with
Distinct Differentiation Potentials.
Front. Cell Dev. Biol. 4:52.
doi: 10.3389/fcell.2016.00052
Glycan Profiling Shows Unvaried
N-Glycomes in MSC Clones with
Distinct Differentiation Potentials
Katherine M. Wilson 1, Jane E. Thomas-Oates 2, Paul G. Genever 1 and Daniel Ungar 1*
1Department of Biology, University of York, York, UK, 2Department of Chemistry and Centre of Excellence in Mass
Spectrometry, University of York, York, UK
Different cell types have different N-glycomes in mammals. This means that cellular
differentiation is accompanied by changes in the N-glycan profile. Yet when the
N-glycomes of cell types with differing fates diverge is unclear. We have investigated
the N-glycan profiles of two different clonal populations of mesenchymal stromal cells
(MSCs). One clone (Y101), when differentiated into osteoblasts, showed a marked shift
in the glycan profile toward a higher abundance of complex N-glycans and more core
fucosylation. Yet chemical inhibition of complex glycan formation during osteogenic
differentiation did not prevent the formation of functional osteoblasts. However, the
N-glycan profile of another MSC clone (Y202), which cannot differentiate into osteoblasts,
was not significantly different from that of the clone that can. Interestingly, incubation of
Y202 cells in osteogenic medium caused a similar reduction of oligomannose glycan
content in this non-differentiating cell line. Our analysis implies that the N-glycome
changes seen upon differentiation do not have direct functional links to the differentiation
process. Thus N-glycans may instead be important for self-renewal rather than for cell
fate determination.
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INTRODUCTION
Mesenchymal stromal cells (MSCs) are a heterogeneous population of cells that contains both adult
multipotent and immunomodulatory cell types (Nauta and Fibbe, 2007). They can be isolated from
several locations in the human body by exploiting their ability to adhere to plastic. MSCs are often
distinguished from other cells types by the expression of CD105, CD73, CD90 cell surface markers
and the absence of hematopoietic markers such as CD45, CD43, CD14, and CD19 (Dominici et al.,
2006). Once isolated, MSCs can be induced to differentiate into bone, cartilage or fat cells, but
not all the cells in a heterogeneous primary isolate behave the same way during a differentiation
experiment. In fact, clonal sub-populations of primary MSCs show different features than the
parent population. Some clones can differentiate into all three lineages. Others are only capable
of dual or single lineage differentiation, while some do not differentiate at all (Pittenger et al.,
1999). In addition, MSCs have been observed to provide immunomodulatory functions, a role
that is shared by both differentiating and non-differentiating cells (Bartholomew et al., 2002; James
et al., 2015). Given the range of phenotypic characteristics and the lack of decisive markers, the
precise identification of MSCs is not trivial in a primary mixture. Moreover, the characterization of
different MSC lines derived from primary cells would also benefit from the elucidation of further
defining molecular features.
Wilson et al. Uniform N-Glycomes in MSC Clones
We generated single cell-derived clones from immortalized
bone-marrow MSCs. Importantly, different clones obtained in
the course of immortalization represent the various cell types
contained in the heterogeneous primary mixture. Four such
clones have been characterized in detail, two of which are capable
of differentiation, while the other two represent MSCs with
enhanced immunomodulatory features that cannot differentiate
(James et al., 2015). The two differentiating lines (Y101 and Y201)
are similar in their gene expression profiles, and both show tri-
lineage differentiation potential, although Y101 cells are primed
for osteogenic differentiation, and do not differentiate efficiently
into adipocytes. The non-differentiating lines (Y102 and Y202)
exhibit little differentiation capacity with possibly a very weak
adipogenic potential, but express a significant proportion of
pro-inflammatory genes, with increased IL-7 production. They
are characterized by the unique cell-surface marker CD317,
and represent approximately 10% of the mixed primary MSC
population. Apart from the inflammatory markers, there are as
yet no clear differences in the four lines that would indicate why
the ’01 lines can and the ’02 lines cannot differentiate. These
MSC lines thus represent excellent models to study the molecular
characteristics of the various MSC populations found in vivo.
Cellular differentiation is accompanied by a change in
glycosylation patterns. For example, the antigens marking
different stages of embryonic stem cell development are glycans
(Gooi et al., 1981). Along similar lines, the N-glycome undergoes
remodeling during embryonic cell differentiation (Amano et al.,
2010). Glycosylation differences also exist between cells that are
at the same stage of differentiation, but have different lineage
commitments, such as the extensive differences observed in lectin
binding affinities for neuronal and mesenchymal progenitor
cells (Dodla et al., 2011). The differentiation of primary MSCs
also leads to glycosylation changes. Glycomic comparison
of adipocytes and their parental MSCs (a heterogeneous
primary population) has uncovered increased sialylation and
decreased branching of complex N-glycans as a consequence of
differentiation (Hamouda et al., 2013). In contrast, osteogenic
differentiation of another heterogeneous primary cell population
has been associated with a decrease in the levels of oligomannose
type N-glycans (Heiskanen et al., 2009). Although many
other changes were observed between MSCs and the derived
osteoblasts, detailed quantification of the differences is skewed
by the fact that glycan permethylation was not used prior
to MALDI-MS analysis, which prevents the quantification of
relative glycan abundances (Wada et al., 2007).
While glycosylation differences are a well-accepted feature of
different cell types, the functional significance of these variations
is less clear. Moreover, it is unknown whether MSC sub-
types with different properties, such as differentiation-competent
MSCs vs. primarily immunomodulatory MSCs, have differences
in their glycosylation profiles.We therefore asked if differences in
the glycosylation state between the various MSC sub-populations
Abbreviations: ALP, Alkaline phosphatase; FANGS, Filter-aided N-glycan
separation; MALDI, Matrix-assisted laser desorption/ionization; MS, Mass
spectrometry; MSC, Mesenchymal stromal cell; SEM, Standard error of the mean;
TOF, Time-of-flight.
in our model cultures could be observed, and could potentially
contribute to phenotypic differences between the MSC subtypes
within a primary mixture. In accordance with previous findings
(Heiskanen et al., 2009), we observed a robust change in the N-
glycan profile during osteogenesis of the tested homogeneous
MSC line. Interestingly, detailed quantitative N-glycan profiling
showed remarkable similarity for two different immortalized
MSC lines (Y101 and Y202) despite their differing phenotypes.
MATERIALS AND METHODS
Cell Culture and Osteogenic Differentiation
Cells were cultured in basal medium composed of DMEM (high
glucose, pyruvate, no glutamine) supplemented with 10% fetal
bovine serum, 1% penicillin/streptomycin, and 1% GlutaMax-
I. To stimulate osteogenesis, cells were seeded at a density
of 20,000 cells/cm2 and 50µg/mL ascorbic acid, 5mM β-
glycerophosphate, and 10 nM dexamethasone were added to
basal medium. Culture medium was changed every 3–4 days
during assays. For histochemistry cells were cultured in 24-well
dishes, for glycan profiling in 10 cm plates.
Preparation of N-glycans for Mass
Spectrometry
The filter-aided N-glycan separation (FANGS) method was
carried out as described (Abdul Rahman et al., 2014). Briefly,
1 × 106 cells were seeded into a 10 cm culture dish and
harvested 24 h later for glycan preparation. Following SDS lysis
and buffer exchange in a centrifugal filter, glycans were released
using PNGase F treatment, and permethylated prior to mass
spectrometric analysis.
Mass Spectrometry
Permethylated glycans were dissolved in 20µL methanol. Two
microliters of this sample was mixed with 1µL of 0.5M
sodium nitrate (in 70% methanol) and 2µL of 20 mg/mL 2,5-
dihydroxybenzoic acid (in 70% methanol). Two microliters of
this mix was spotted onto a ground steel MALDI target plate
(Bruker) and allowed to air dry. Immediately afterwards, 0.2µL
of ethanol was added to the spot and left to air dry for re-
crystallization. Samples were analyzed using an ultraflex III
MALDI-TOF mass spectrometer (Bruker). The spectra were
acquired over the m/z range 800–6000 using positive-ion mode,
with 4000 laser shots in steps of 800, which were summed to give
one spectrum per spot. The SmartbeamTM laser power was set to
50–65%.
Data Analysis
Spectra were analyzed using flexAnalysis 3.3 (Bruker), first
processed using the centroid peak detection algorithm, using a
signal to noise limit of 3, and smoothed for 1 cycle at 0.1 m/z,
using the Savitzky-Golay algorithm. Glycan peaks were identified
from their mono-isotopic peak m/z values on comparison with
those for established N-glycan structures. For a glycan to be
included in the analysis at least two of its isotopic peaks had to
have intensities>3x the noise, and the associated peaks had to fall
into an isotopic pattern as predicted based on the glycan’s atomic
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composition (Bruker Compass’s Isotope Pattern function). The
peak intensities of all isotope signals >3x noise for a given glycan
were summed to provide that glycan’s total peak intensity. To
compare different spectra, the total peak intensity values were
normalized to the total peak intensities of all glycans identified
in that spectrum. Normalized peak intensities could then be
averaged across different spectra of the same sample type.
Flow Cytometry Analysis
Cells were washed twice with PBS, and incubated with washing
buffer (0.2% bovine serum albumin, 5mMEDTA in PBS) at 37◦C
until cells detached. Cells were centrifuged for 5min at 450 g,
resuspended in PBS and 150,000 cells pelleted and resuspended
in 120µL ice-cold PBS. Following 15min incubation on ice,
120µL of 10µg/mL FITC-ConA (Vector Labs) was added to
each sample. After two 15min incubations interspersed with
flicking of the tubes, 1mL of washing buffer was added and the
samples were centrifuged for 5min at 450 g. The cell pellet was
resuspended in 100µL of washing buffer containing 1µg/mL
DAPI and incubated on ice in the dark for 5min, followed by
the addition of 1mL washing buffer, and centrifugation for 5min
at 450 g. The pellet was resuspended in 400µL PBS for flow
cytometry. Data were gated for DAPI-negative FITC-positive
cells. Median fluorescence intensity was determined for all gated
cells in the sample.
Analysis of cell surface markers was performed as previously
described (James et al., 2015).
Statistics
Data were analyzed using Sigma Plot 12.3. Before statistical
tests were applied, a normality test (Shapiro–Wilk) and a test of
equal variance was performed. For comparing two groups if data
passed, a Student’s T-test was carried out. Otherwise, one-way
ANOVA tests were carried out, followed by Holm Sidak post-hoc
tests if required. If the data failed the normality or variance tests,
equivalent non-parametric tests were applied instead. Either a
Mann–Whitney test when two groups were being compared, or a
Kruskal–Wallis one-way ANOVA on ranks, followed by Dunn’s
post-hoc tests was carried out if more than one group was being
compared. Throughout ∗ : P < 0.05, ∗∗ : P < 0.01, and ∗∗∗ : P <
0.001.
RESULTS
Osteogenic Differentiation of Y101 Cells
Alters Their N-glycan Profile
To study the sub-type-specific properties of cells from a
primary human MSC mixture, previously generated telomerase
immortalized lines derived from primary human MSCs, termed
hTERT-MSCs (James et al., 2015), were used. The N-glycans
of one of these lines, Y101, were profiled using the FANGS
method (Abdul Rahman et al., 2014). Figure 1 shows a typical
N-glycan profile of Y101 cells in which as many as 65 different
glycan species were detected. The glycan profile is qualitatively
comparable with those reported for primary MSCs (Heiskanen
et al., 2009; Hamouda et al., 2013), although different glycan
classes cannot be quantitatively compared with those reported in
the older studies, due to their different analysis strategies. The
most abundant glycans we observe in these cells are the Man6-
Man9 oligomannose species (m/z 1783.85, 1987.93, 2192.03, and
2396.14). Among the complex glycans, the singly sialylated,
fucosylated biantennary species (m/z 2605.24), followed closely
by the same glycan without sialic acid (m/z 2244.08) and then
the bis-sialylated version (m/z 2966.42) are most abundant. It is
worth noting that the majority of the large complex glycans are
fucosylated (e.g.,m/z 4226.04, 4314.14, 4587.21, 4676.28, 4764.41,
5037.41, and 5124.57), whichmost likely indicates the presence of
core fucose.
Changes in the N-glycan profile of primary MSCs upon
differentiation have been reported (Heiskanen et al., 2009),
again with the caveat that that analysis did not allow detailed
quantification. The telomerase-immortalized Y101 cell line is
capable of robust osteogenic differentiation in vitro (James
et al., 2015). This is demonstrated when the cells are stained
for secreted alkaline phosphatase (ALP, pink staining) and
hydroxyapatite mineral deposits (brown) with an ALP/von Kossa
stain at 7 day intervals over a 3 week period (Figure 2A). It is
clear from appearance of the pink ALP stain and the stained
phosphate deposits that 21 days in osteogenic medium gives
strong differentiation (Figure 2A bottom row “21 days” image).
These differentiated cells were harvested and their total N-glycan
repertoire analyzed using FANGS followed by MALDI-TOF-
MS (Figure 2B). The resulting spectra show a very different
picture than that from the undifferentiated MSCs. Importantly,
the observed changes in glycosylation during osteogenesis were
not due to the 21 days spent in culture. When Y101 MSCs
were cultured in basal rather than osteogenic medium for
21 days (a treatment that does not promote osteogenesis)
the N-glycan spectra obtained were similar to those from
MSCs at the start of the incubation period (Figures 2E,F and
Supplementary Figure 1). In the differentiated osteoblasts, by
far the most abundant glycan peak is now the singly sialylated,
fucosylated biantennary complex glycan species (m/z 2605.22),
followed, at about half the intensity, by the same complex glycan
without sialic acid (m/z 2244.08) and the fully sialylated species
(m/z 2966.39). The most abundant oligomannose glycan in
osteoblasts, theMan6 species (m/z 1783.87), is only ranked fourth
in relative intensity in the N-glycome of osteoblasts (Figure 2B,
Table 1).
Averaging the glycan peak intensities from several biological
replicates showed that the most abundant complex glycans were
indeed reproducibly much more abundant in osteoblasts than
undifferentiated MSCs (Figure 2C, Table 1). In contrast, the
large oligomannose glycans all had very low abundances in the
N-glycomes of osteoblasts, although these are among the most
abundant glycans in those of the MSCs (Figure 2C, Table 1).
Similarly, the singly glucosylated oligomannose glycan species
was undetectable from osteoblasts, although it was notably
present from MSCs (m/z 2600.22 Figures 1, 2D, Table 1). There
was also a trend toward increased abundance of hybrid glycans
in osteoblasts (Figure 2D, Table 1). Differences are even more
evident when the total oligomannose and complex glycan levels
are compared. The reduction in relative levels of oligomannose
glycans and the increase in complex glycans are both highly
Frontiers in Cell and Developmental Biology | www.frontiersin.org 3 May 2016 | Volume 4 | Article 52
Wilson et al. Uniform N-Glycomes in MSC Clones
FIGURE 1 | N-glycan profile of Y101 hTERT-MSC line. Representative MALDI-TOF spectrum of permethylated N-glycans isolated from the Y101 hTERT-MSC line.
Peaks were annotated based on the calculated glycan mass and knowledge of the glycan biosynthesis pathway. m/z value of the mono-isotopic peak is labeled, with
the predicted structure pictured above. Spectrum shown is from m/z 1000 to 5250 split into two sections. Note that the sections are plotted on different y axis scales
to make the higher m/z range section easier to see.
significant (Figure 2E). There is also a significant increase in the
total amount of fucosylated species detected from the osteoblasts
over that from their MSC progenitors (Figure 2F), although
glycan species with multiple fucoses were more prevalent in the
MSCs (Table 1).
MSC Lines Share a Similar N-glycan Profile
Independent of Their Altered
Differentiation Potentials
Given that differentiation considerably alters the N-
glycan profile, we wondered whether MSCs with diverse
differentiation abilities present variations in N-glycan profiles.
We compared two hTERT-MSC lines: Y101 and Y202. Y101
cells differentiate well into osteoblasts. Y202 cells in contrast,
which do show the cell surface markers characteristic of MSCs
(Supplementary Figure 3; Dominici et al., 2006), are virtually
devoid of differentiation potential (James et al., 2015) as
exemplified by the lack of ALP and von Kossa staining, used to
detect osteogenesis (Figure 3A bottom row).
To assess if the differences in differentiation capacity
between the different clonal MSC lines are associated with
a variation in their N-glycan repertoire, we used FANGS
followed by MALDI-TOF-MS to profile their glycans. Both
MSC lines were cultured for 24 h in basal medium post
passaging, prior to N-glycan sample harvest and analysis.
The overall N-glycan profiles of these lines look very similar
to each other (Figure 3B). Profiling of several biological
replicates for the same cell lines followed by averaging of the
relative glycan abundances revealed no significant differences at
all (Supplementary Figures 2A,B and Supplementary Table 1).
This lack of difference is also apparent when comparing
different glycan classes (Supplementary Figures 2C,D). A heat
map generated using the averaged relative abundances of all
glycans from the two different MSC lines, Y101 and Y202, and
the osteoblasts derived from Y101 cells clearly shows that the
main change in N-glycan profile is between the MSCs and the
differentiated progeny, rather than within the different lines of
MSCs (Figure 3C).
It is clear that differentiation alters the glycan profile, yet
the glycan profile of the stem cells does not provide clues
to their differentiation potential. We therefore wondered if
the glycosylation changes are restricted to cells undergoing
differentiation, or whether non-differentiating cells, when
incubated under differentiation-promoting conditions, alter their
glycan profiles. The reduction of oligomannose glycan content
was investigated for MSCs incubated in osteogenic medium
for 8 days. As expected, Y101 cells showed a clear reduction
in oligomannose content, as evidenced by reduced ConA-
FITC staining measured using flow cytometry when compared
with cells cultured in basal medium (Figure 3D, second and
third bars). The lectin ConA binds oligomannose glycans, and
is therefore a sensitive tool for uncovering changes in the
proportion of this glycan class. Surprisingly, Y202 cells, which
do not formmineral deposits, showed the same highly significant
reduction in oligomannose content when incubated in osteogenic
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FIGURE 2 | Osteogenic differentiation significantly alters the N-glycan profile of MSCs. (A) Brightfield images of Y101 hTERT-MSCs cultured in basal (top
row) or osteogenic (bottom row) media, stained for alkaline phosphatase (pink) and phosphate (von Kossa, brown), sampled at weekly intervals. (B) A representative
MALDI-TOF spectrum of permethylated N-glycans isolated from osteoblasts cultured for 21 days as in (A). Presented as in Figure 1. (C–F) Comparisons of averaged
(Y101 n = 5, osteoblast n = 3) normalized total peak intensities of: (C) Individual glycan structures with abundances above 3% of the total. (D) Individual glycan
structures with abundances of 1–3% of the total. D.P, degradation product, most likely produced in the lysosome. (E) Sums of different glycan types. (F) Sums of all
fucosylated glycan abundances. Error bars show standard error of the mean. In (E, F) the “Basal medium 21 days” sample was harvested following culture in basal
medium for 21 days (n = 2). For a representative spectrum of this sample see Supplementary Figure 1. *P < 0.05, **P < 0.01, ***P < 0.001.
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TABLE 1 | Averaged relative abundances of individual N-glycan structures isolated from Y101 hTERT-MSCs and their osteoblast progeny as well as MSCs
kept for 21 days in basal medium.
Glycan composition Typea Average relative abundanceb
MSC Osteoblast 21 day basal
Hex5HexNAc2 O 2.394±0.120 3.505±1.182 7.095± 1.526
Fuc1Hex5HexNAc2 O 0.621±0.215 0.187±0.187 0.885± 0.405
Hex6HexNAc2 O 10.740±0.998 6.846±1.639 13.342± 2.521
Hex7HexNAc2 O 6.470±0.480 3.010±0.499 6.258± 1.252
Hex8HexNAc2 O 13.042±0.894 3.476±0.160 9.089± 0.790
Hex9HexNAc2 O 10.693±0.825 2.383±0.345 5.174± 0.521
Hex10HexNAc2 O 1.119±0.154 0 0.186± 0.062
Hex5HexNAc3 H 0.584±0.114 0.509±0.328 0.615± 0.166
Hex6HexNAc3 H 0.212±0.130 0.638±0.370 0.916± 0.192
Hex6HexNAc4 H 0.965±0.217 1.557±0.483 1.246± 0.351
NeuAc1Hex6HexNAc3 H 0.432±0.184 0.594±0.302 0.709± 0.090
NeuAc1Fuc1Hex6HexNAc3 H 0.032±0.032 0 0
Hex7HexNAc5 H 0.438±0.127 0.207±0.089 0.125± 0.040
NeuAc2Hex6HexNAc4 H 0.581±0.108 1.032±0.084 0.304± 0.269
Hex8HexNAc6 H 0.066±0.031 0 0
Hex3HexNAc3 C 0.004±0.004 0.178±0.178 0.091± 0.112
Fuc1Hex3HexNAc3 C 0.431±0.084 0.185±0.185 0.292± 0.195
Hex4HexNAc3 C 0.335±0.085 0.197±0.197 0.323± 0.112
Fuc1Hex3HexNAc4 C 0.686±0.106 0.126±0.126 0.287± 0.101
Hex4HexNAc4 C 0.285±0.056 0.089±0.089 0.224± 0.134
Fuc1Hex4HexNAc4 C 0.552±0.119 0 0
Hex5HexNAc4 C 2.151±0.214 1.622±0.485 3.370± 0.447
Fuc1Hex3HexNAc5 C 0.297±0.093 0 0.000± 0.138
NeuAc1Fuc1Hex4HexNAc3 C 0.379±0.104 0.139±0.139 0.597± 0.269
Fuc1Hex5HexNAc4 C 8.259±0.655 12.271±1.386 11.951± 2.082
NeuAc1Fuc1Hex5HexNAc3 C 0 0.138±0.138 0.337± 0.132
NeuAc1Hex5HexNAc4 C 3.040±0.347 3.757±0.367 3.330± 0.169
Hex6HexNAc5 C 0.383±0.123 0.088±0.088 0.204± 0.045
NeuAc1Fuc1Hex5HexNAc4 C 11.968±0.722 25.387±2.830 12.152± 4.007
NeuGc1Fuc1Hex5HexNAc4 C 1.348±0.273 3.712±0.423 1.346± 0.789
Fuc1Hex6HexNAc5 C 1.661±0.213 1.171±0.382 0.590± 0.184
NeuAc2Hex5HexNAc4 C 1.421±0.340 1.808±0.547 0.619± 0.078
NeuAc1Fuc1Hex5HexNAc5 C 0.143±0.059 0 0
NeuAc1Hex6HexNAc5 C 0.461±0.101 0.314±0.150 0.125± 0.033
NeuGc1Hex6HexNAc5 C 0.252±0.052 0.140±0.112 0.040± 0.032
NeuAc2Fuc1Hex5HexNAc4 C 4.784±0.583 7.695±1.401 2.957± 1.398
NeuAc1Fuc1Hex6HexNAc5 C 2.102±0.360 1.827±0.904 0.599± 0.323
NeuGc1Fuc1Hex6HexNAc5 C 0.351±0.086 0.241±0.103 0.071± 0.044
Fuc1Hex7HexNAc6 C 0.398±0.084 0.134±0.082 0.043± 0.028
NeuAc2Hex6HexNAc5 C 0.248±0.096 0.274±0.050 0.249± 0.238
NeuAc1Fuc6Hex4HexNAc4 C 0.025±0.016 0 0
NeuAc2Fuc3Hex5HexNAc4 C 0.011±0.011 0 0
NeuAc1Hex7HexNAc6 C 0.091±0.030 0 0
NeuAc2Fuc1Hex6HexNAc5 C 1.228±0.269 1.670±0.932 0.345± 0.328
NeuAc1NeuGc1Fuc1Hex6HexNAc5 C 0.126±0.036 0.210±0.097 0.037± 0.057
NeuAc1Fuc1Hex7HexNAc6 C 0.588±0.147 0.321±0.242 0.058± 0.049
NeuAc1Hex8HexNAc6 C 0.075±0.029 0.042±0.042 0.000± 0.013
NeuGc2Hex6HexNAc6 C 0.014±0.014 0.058±0.058 0
(Continued)
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TABLE 1 | Continued
Glycan composition Typea Average relative abundanceb
MSC Osteoblast 21 day basal
NeuAc3Hex6HexNAc5 C 0.657±0.268 2.034±1.445 0.027± 0.033
NeuAc2NeuGc1Hex6HexNAc5 C 0.045±0.027 0.288±0.194 0
NeuAc2Hex7HexNAc6 C 0.077±0.041 0.092±0.092 0
NeuAc1NeuGc1Hex7HexNAc6 C 0 0.054±0.054 0
NeuAc3Fuc1Hex6HexNAc5 C 0.373±0.114 0.993±0.611 0.089± 0.135
NeuAc2NeuGc1Fuc1Hex6HexNAc5 C 0.036±0.015 0.167±0.100 0.014± 0.028
NeuAc2Fuc1Hex7HexNAc6 C 0.520±0.176 0.735±0.587 0.068± 0.104
NeuAc1NeuGc1Fuc1Hex7HexNAc6 C 0.038±0.025 0.088±0.076 0.009± 0.018
NeuAc1Fuc1Hex8HexNAc7 C 0.047±0.030 0 0
NeuAc4Hex6HexNAc5 C 0.083±0.043 0.377±0.255 0
NeuAc1Fuc1Hex7HexNAc8or
c
NeuAc3NeuGc1Hex6HexNAc5
C 0 0.065±0.040 0
NeuAc3Hex7HexNAc6 C 0.023±0.014 0.037±0.037 0
NeuAc2Hex8HexNAc7 C 0.004±0.004 0.024±0.024 0
NeuAc1NeuGc1Hex8HexNAc7 or
c
NeuGc2Fuc1Hex7HexNAc7
C 0 0.016±0.016 0
NeuAc3Fuc1Hex7HexNAc6 C 0.174±0.077 0.427±0.332 0.024± 0.057
Fuc2Hex8HexNAc9 or
c
NeuAc3Hex8HexNAc6
C 0 0.057±0.047 0.000± 0.009
NeuAc2Fuc1Hex8HexNAc7 C 0.033±0.020 0.070±0.060 0.000± 0.006
NeuAc4Fuc1Hex7HexNAc6 C 0.046±0.024 0.233±0.177 0.005± 0.017
NeuAc3Fuc1Hex8HexNAc7 C 0.016±0.010 0.061±0.051 0
NeuAc2Fuc1Hex9HexNAc8 C 0.008±0.005 0.013±0.013 0
NeuAc4Fuc1Hex8HexNAc7 C 0.002±0.002 0.019±0.014 0
NeuAc3Fuc1Hex9HexNAc8 C 0.001±0.001 0.011±0.011 0
Fuc1Hex2HexNAc2 DP
d 0.745±0.190 0.746±0.221 1.955± 0.311
Hex3HexNAc2 DP 0.891±0.220 1.053±0.422 2.830± 0.603
Fuc1Hex3HexNAc2 DP 2.402±0.504 3.291±1.230 6.714± 1.163
Hex4HexNAc2 DP 0.618±0.106 1.216±0.282 1.641± 0.323
Fuc1Hex4HexNAc2 DP 0.396±0.095 0 0.571± 0.227
aGlycans grouped as oligomannose (O), hybrid (H), complex (C), and degradation product (DP).
bPercentage of total glycan signal ± SEM for n = 5 (MSC), n = 3 (osteoblast) and n = 2 (21 day basal) are shown.
cGiven the mass of these glycans other glycan compositions are possible, but the most plausible two possibilities are shown.
dDP are small glycans that are not produced by the mammalian N-glycosylation machinery and therefore most likely originate from lysosomal degradation.
medium (Figure 3D, fifth and sixth bars). Thus although Y202
cells do not differentiate intomineral-depositing osteoblasts, they
do undergo a significant change, which results in a glycan profile
alteration similar to that of osteoblastic Y101 cells.
As a second test we wondered if glycosylation changes
are necessary for differentiation into osteoblasts to take place.
We used the glycan-processing inhibitor swainsonine, which
inhibits mannosidase II. As expected, this caused a major
shift in the glycan profile, in which complex glycans almost
completely disappeared, and were replaced by hybrid ones
(Supplementary Figure 4). This allowed us to test whether the
shift to complex glycans is required for osteogenesis. While there
was a slight reduction in the amount of mineral deposition
when the cells where grown in osteogenic medium in the
presence of swainsonine, the cells were clearly still capable of
forming osteoblasts and depositing calcium phosphate mineral
(Figure 3E).
DISCUSSION
A previous glycomic study concluded that oligomannose glycans
are more abundant in parental stem cells than in their
differentiated osteoblasts (Heiskanen et al., 2009). As the glycans
in that study were not permethylated a true quantitative
assessment of the relative abundance of the various glycan species
was not possible (Wada et al., 2007). Our study now provides
a detailed quantitative comparison of the MSC and osteoblast
glycan profiles of clonal lines made possible by the FANGS
method. We find that oligomannose and complex glycans are
close to equally abundant in MSCs, while this changes to an
almost four-fold higher abundance of the complex glycans in
osteoblasts. Shifts in the glycan profile upon differentiation have
been reported using quantitative methods such as the MALDI-
MS of permethylated glycans and LC-MS of fluorescently labeled
glycans (Wada et al., 2007; Hasehira et al., 2012). Comparing
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FIGURE 3 | N-glycan profile of MSCs does not correlate with differentiation capacity. (A) Osteogenic capacities of Y101 and Y202 hTERT-MSC lines. For
details see Figure 2A. (B) N-glycan profiles of the Y101 and Y202 hTERT-MSC lines following 24 h culture in basal medium. Representative MALDI-TOF spectra as in
Figure 1, but glycan assignments are omitted for clarity. (C) Heat map display comparing the N-glycan profiles of Y101, Y202 hTERT-MSCs, and osteoblasts derived
from the Y101 hTERT-MSCs. Averaged (Y101, Y202 n = 5, osteoblasts n = 3) normalized peak intensities were compared. Each row in the heat map display
represents a single glycan structure. Glycans are grouped by type: oligomannose (O), hybrid (H), or complex (C), and sorted by abundance in the Y101 profile within
each type. The cells’ colors denote glycan abundance as indicated in the legend. (D) Y101 or Y202 cells were grown for 0 or 8 days in basal or osteogenic (osteo)
medium, then single cell suspensions stained with ConA-FITC and DAPI and analyzed by flow cytometry. The median intensity of the FITC fluorescence of live cells is
shown with SEM from three independent replicates. (E) Y101 cells were cultured in basal medium containing 10µg/mL swainsonine for 48 h before addition of
osteogenic medium containing swainonsine at the same concentration. Mineral deposition and ALP activity were tested by ALP/von Kossa staining 0, 7, 14, and 21
days after addition of osteogenic medium. ***P < 0.001.
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neuronal stem cells and their differentiated progeny, (Yagi et al.,
2012) or embryonic stem cells and embryoid bodies (Nairn
et al., 2012), showed reductions in oligomannose glycans in
the differentiated cells. Along similar lines, the reverse process,
generation of induced pluripotent stem (iPS) cells, increased
the oligomannose proportion of the glycan profile (Hasehira
et al., 2012). None of these comparisons reported a shift in
the proportion of oligomannose vs. complex glycans as large as
that observed in our study. A likely explanation is that most
studies have not compared terminally differentiated specialized
cells, but intermediate or mixed stages of differentiation. This
possibility is corroborated by the glycomic profiles published
for embryonic stem cells and terminally differentiated fibroblasts
(An et al., 2012). This latter study used clonal lines, just
as our study does, but did not use permethylated glycans,
so their quantification is imperfect. Moreover, the fibroblasts
investigated were not derived from the stem cells analyzed, so the
comparison is largely between a generic stem cell and a generic
differentiated cell population, rather than the consequence of
the differentiation process per se as in our study. Nevertheless,
the shift in oligomannose glycan abundance from 70 to 80%
in the stem cells to 30% in the fibroblasts (An et al., 2012)
is close to the range that we now report. Our results would
therefore be in line with the hypothesis that stemness may require
oligomannose glycans (Heiskanen et al., 2009; Hamouda et al.,
2013).
Another change within the glycan profile is increased overall
fucosylation intensity in osteoblasts. Single fucosylation could
be present either on the core or the antennae, but glycans with
multiple fucoses have to contain fucose on the antennae. From
MSCs we observed several glycans with multiple fucoses as
opposed to osteoblasts where single fucosylation predominates.
Thus while the overall intensity of fucosylation is elevated in
osteoblasts, the level of fucosylation on antennae is likely higher
in the stem cells, leading us to speculate that fucosylation on the
antennae could be a property of stem cells rather than osteoblasts
(Figures 1, 2B and Table 1). Indeed, iPS cells have been shown
to have a lower degree of core fucosylation but more on the
antennae than their differentiated parents (Hasehira et al., 2012).
In addition, Fut9-dependent fucose addition to the antennae has
been implicated in embryonic stem cell self-renewal (Li et al.,
2009).
Comparison of the two MSC lines shows a remarkable
similarity in their N-glycan profiles, despite a marked difference
in their differentiation capabilities. The profiles of the stem
cell lines we report are also similar to the previously reported
profiles of primary MSCs (Heiskanen et al., 2009; Hamouda
et al., 2013). We would therefore argue that N-glycan profiles
are a good indicator of overall MSC identity. Importantly,
changes to the glycan profile following prolonged culturing
of the stem cells are also small, enforcing the usefulness of
glycans as an MSC marker. The main difference between the
glycan profiles of MSCs before and after prolonged culturing
is a significantly higher abundance of degradation products
(Table 1). The appearance of such N-glycans that cannot be
made during biosynthetic processing in mammals is most likely
a consequence of intermediates accumulating in the lysosome
during glycan degradation (Uematsu et al., 2005). These are
picked up in our analysis due to the FANGS process capturing
all cellular protein-linked N-glycans. The amount of these glycan
species in the MSCs and osteoblasts is in line with the levels of
paucimannose glycans found in other glycan profiling studies
of cultured cells (Abdul Rahman et al., 2014). The increased
proportion of this glycan class in the cells that were cultured
for 21 days may be explained by increased autophagy and/or
cell death, possible consequences of over-confluency due to
the lack of differentiation. A further conclusion we can make
from these observations is that the differences between MSC
and osteoblast glycan profiles are not due to the extended
culture time, but rather are genuine differentiation-associated
changes.
A major question in glycobiology is the function of glycans
during cellular processes. While it is well documented that there
are changes in glycan profiles between cell types, the functional
consequence of these changes is unclear. Our results suggest that
the shift to complex N-glycans in MSCs is neither required nor
sufficient alone to drive osteogenesis. Inhibition of complex N-
glycan formation by swainsonine does not inhibit osteogenesis.
In contrast, the shift to a lower proportion of oligomannose
glycans in Y202 cells is not accompanied by osteoblast mediated
mineralization. Rather, it could more likely be the stem-like
properties of MSCs that may benefit from certain glycan features.
Our detailed analysis of two MSC cell lines allows us to
speculate about the requirements for the various glycan subtypes
of different stem cell functions. Given that the Y202 line, which is
unable to differentiate effectively, has the same N-glycan profile
as the differentiating Y101 MSC line, it is unlikely that glycans
directly determine the differentiation potential of these cells.
However, continued proliferation and self-renewal are also very
important properties of stem cells. Indeed terminal fucosylation
has been suggested to be an important factor in stem cell
maintenance (Li et al., 2009). It is therefore a possibility that some
of the features of the profiles found in both the differentiating and
undifferentiating MSC lines, which are absent from osteoblasts,
such as increased oligomannose content or the fucosylation of
antennae, may contribute to the maintenance of a proliferative
phenotype.
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Supplementary Table 1 | Comparison of averaged glycan abundances for
the hTERT-MSC lines Y101 and Y202.
Supplementary Figure 1 | Representative MALDI-TOF spectrum of
permethylated N-glycans harvested from MSCs grown for 21 days in
basal medium. For details see Figure 1.
Supplementary Figure 2 | Comparison of Y101 and Y202 N-glycans, for
details see Figures 2C–F. Comparisons of averaged (n = 5) Y101 and Y202
normalized N-glycan total peak intensities of: (A) Individual glycan structures with
abundances above 3% of the total. (B) Individual glycan structures with
abundances of 1–3% of the total. D.P, degradation product, most likely produced
in the lysosome. (C) Sums of different glycan types. (F) Sums of all fucosylated
glycan abundances. Error bars show standard error of the mean.
Supplementary Figure 3 | Presence and absence of the indicated cell
surface CD markers was determined for Y202 cells using flow cytometry.
Supplementary Figure 4 | Comparison of representative MALDI-TOF
spectra of N-glycans harvested from Y101 MSCs cultured for 48h in the
presence or absence of swainsonine. The assigned glycan structures are only
shown for the most prominent peaks.
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